Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of molecular profile-guided chemotherapy in previously treated metastatic or locally advanced cancer
MOH_2024-09-11_013632Phase 2Not yet recruiting
- Sponsor
- פרופ' יובל טבח
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of gemcitabine, methotrexate and fluorouracil in cancer (3 arms), sponsored by פרופ' יובל טבח. Primary endpoint: Tumor diameter by CT imaging. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
gemcitabinemethotrexatefluorouracil
03
Conditions
cancer
Beyond the preview
Go deeper on MOH_2024-09-11_013632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-09-11_013632.